je.st
news
Tag: diabetes
FDA: AstraZeneca's diabetes drug showed increased death risk
2015-04-11 13:08:02| Biotech - Topix.net
AstraZeneca PLC's type 2 diabetes drug Onglyza showed an increased risk of death in an analysis by U.S. regulators of a clinical trial on the heart effects of the treatment. Food and Drug Administration staff said their analysis of deaths in the trial suggested patients using Onglyza experienced "significant or near-significant" increases in death from all causes, not just heart problems.
Tags: death
increased
risk
drug
Yoghurt and cheese could reduce type 2 diabetes risk
2015-04-07 01:00:00| Food Processing Technology
A study by Sweden's Lund University has found that consuming high-fat yoghurt and cheese could lead to a reduction in the risk of type 2 diabetes by as much as a fifth.
More diabetes cases diagnosed after Medicaid expansion
2015-03-25 16:16:52| Biotech - Topix.net
U.S. states that expanded their Medicaid programs under the Affordable Care Act have seen larger increases in diabetes cases than states that didn't expand their programs, a new study shows. The findings suggest that expanding Medicaid, the government-run health insurance for the poor, allows people with diabetes to be diagnosed earlier than before, which may improve outcomes later on, the researchers say.
Tags: cases
expansion
diabetes
diagnosed
Lifestyle intervention program at workplace reduces risk factors for diabetes, heart disease
2015-03-09 06:53:49| Chemicals - Topix.net
A healthy lifestyle intervention program administered at the workplace and developed by the University of Pittsburgh Graduate School of Public Health significantly reduces risk factors for diabetes and heart disease, according to a study reported in the March issue of the Journal of Occupational and Environmental Medicine . The program was well-received by participants at Bayer Corp., who lost weight and increased the amount of physical activity they got each day, when compared with a control group in the study, which was funded by the National Institutes of Health.
Tags: program
heart
risk
factors
Lilly delays submission to market once-daily diabetes drug
2015-02-23 16:03:04| Biotech - Topix.net
Eli Lilly and Co said it would delay its application to market its once-daily diabetes treatment, basal insulin peglispro, beyond the current quarter. REUTERS: Eli Lilly and Co said it would delay its application to market its once-daily diabetes treatment, basal insulin peglispro, beyond the current quarter.
Tags: market
drug
submission
delays
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »